Active Learning for Computational Chemogenomics
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
AIM: Computational chemogenomics models the compound-protein interaction space, typically for drug discovery, where existing methods predominantly either incorporate increasing numbers of bioactivity samples or focus on specific subfamilies of proteins and ligands. As an alternative to modeling entire large datasets at once, active learning adaptively incorporates a minimum of informative examples for modeling, yielding compact but high quality models. Results/methodology: We assessed active learning for protein/target family-wide chemogenomic modeling by replicate experiment. Results demonstrate that small yet highly predictive models can be extracted from only 10-25% of large bioactivity datasets, irrespective of molecule descriptors used. CONCLUSION: Chemogenomic active learning identifies small subsets of ligand-target interactions in a large screening database that lead to knowledge discovery and highly predictive models.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Breiman, L. (2001) · Machine Learning · doi:10.1023/a:1010933404324 · Cited by 133,538
Biopython: freely available python tools for computational molecular biology and bioinformatics
Cock, P. J. A., Antao, T., Chang, J. T., Chapman, B. A., Cox, C. J., Dalke, A., Friedberg, I., Hamelryck, T., Kauff, F., Wilczynski, B., et al. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp163 · Cited by 6,080 · cited 1×
“…individual target and is augmented by a time-series heatmap reflecting that target’s specific MCC trajectory, were constructed using neighbor joining as implemented in the BioPython package (version 1.65) [77] , based on the protein–protein distance matrix generated by the local alignment kernel.”
MethodInfluentialPubChem Substance and Compound databases
Kim, S., Thiessen, P. A., Bolton, E. E., Chen, J., Fu, G., Gindulyte, A., Han, L., He, J., He, S., Shoemaker, B. A., et al. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkv951 · Cited by 5,436 · cited 1×
“Critically, this will require additional work on larger databases, such as STITCH [86] , the SARfari superset ChEMBL [59] or PubChem [87] .”
MethodComparison of the predicted and observed secondary structure of T4 phage lysozyme
Matthews, B. W. (1975) · Biochimica et Biophysica Acta (BBA) - Protein Structure · doi:10.1016/0005-2795(75)90109-9 · Cited by 5,399 · cited 1×
“First, we compared picking strategies by using the Mat-thews correlation coefficient (MCC) [73] of a model at each iteration of each execution for each strategy, where the full set of input CPIs was used for evaluation to ensure a comparability of the values obtained from different runs (see Box 6…”
MethodPredicting new molecular targets for known drugs
Keiser, M. J., Setola, V., Irwin, J. J., Laggner, C., Abbas, A. I., Hufeisen, S. J., Jensen, N. H., Kuijer, M. B., Matos, R. C., Tran, T. B., et al. (2009) · Nature · doi:10.1038/nature08506 · Cited by 1,667
Automated design of ligands to polypharmacological profiles
Besnard, J., Ruda, G. F., Setola, V., Abecassis, K., Rodriguiz, R. M., Huang, X.-P., Norval, S., Sassano, M. F., Shin, A. I., Webster, L. A., et al. (2012) · Nature · doi:10.1038/nature11691 · Cited by 832
Deep Learning in Drug Discovery
Gawehn, E., Hiss, J. A., & Schneider, G. (2016) · Molecular Informatics · doi:10.1002/minf.201501008 · Cited by 723 · cited 1×
“Current complex machine learning models, for example following ‘deep learning’ principles [41,42] , that are trained on comprehensive datasets are still difficult to interpret, and result in performances that are as of yet insignificant compared with existing methodologies.”
Self-citationCan we rationally design promiscuous drugs?
HOPKINS, A., MASON, J., & OVERINGTON, J. (2006) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2006.01.013 · Cited by 469
Protein-protein interaction networks and biology—what's the connection?
Hakes, L., Pinney, J. W., Robertson, D. L., & Lovell, S. C. (2008) · Nature Biotechnology · doi:10.1038/nbt0108-69 · Cited by 200 · cited 1×
“In particular, large ligand–target networks have been reported to suffer from a strong target selection bias [43] , which may force models to learn historic target preferences rather than identifying informative ligand–target patterns [44] .”
Backgroundvan Westen, G. J. P., Wegner, J. K., IJzerman, A. P., van Vlijmen, H. W. T., & Bender, A. (2011) · MedChemComm · doi:10.1039/c0md00165a · Cited by 176 · cited 1×
“Retrospective studies and a slowly rising number of prospective validations have shown that various machine learning techniques are indeed capable of navigating the interface of chemical and biological spaces [23,33] .”
Background
Cited by
Concepts of Artificial Intelligence for Computer-Assisted Drug Discovery
Yang, X., Wang, Y., Byrne, R., Schneider, G., & Yang, S. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00728 · Cited by 1,022
Self-citationSchneider, G. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.232 · Cited by 910
Self-citationRethinking drug design in the artificial intelligence era
Schneider, P., Walters, W. P., Plowright, A. T., Sieroka, N., Listgarten, J., Goodnow, R. A., Fisher, J., Jansen, J. M., Duca, J. S., Rush, T. S., et al. (2020) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0050-3 · Cited by 894
Self-citationIdentification of neoantigens for individualized therapeutic cancer vaccines
Lang, F., Schrörs, B., Löwer, M., Türeci, Ö., & Sahin, U. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00387-y · Cited by 534
Artificial intelligence in drug discovery: recent advances and future perspectives
Jiménez-Luna, J., Grisoni, F., Weskamp, N., & Schneider, G. (2021) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2021.1909567 · Cited by 464
Self-citationApplications of Deep Learning in Molecule Generation and Molecular Property Prediction
Walters, W. P., & Barzilay, R. (2021) · Accounts of Chemical Research · doi:10.1021/acs.accounts.0c00699 · Cited by 382
Synthetic organic chemistry driven by artificial intelligence
de Almeida, A. F., Moreira, R., & Rodrigues, T. (2019) · Nature Reviews Chemistry · doi:10.1038/s41570-019-0124-0 · Cited by 303
Classifiers and their Metrics Quantified
Brown, J. B. (2018) · Molecular Informatics · doi:10.1002/minf.201700127 · Cited by 82
Self-citationProteochemometrics – recent developments in bioactivity and selectivity modeling
Bongers, B. J., IJzerman, A. P., & Van Westen, G. J. P. (2019) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2020.08.003 · Cited by 54
Metadata
- Authors
- Reker, D., Schneider, P., Schneider, G., & Brown, J.
- Venue
- Future Medicinal Chemistry
- Publisher
- Informa UK Limited
- Published
- 2017-03
- Volume
- 9
- Issue
- 4
- Pages
- 381-402
- ISSN
- 1756-8919 (ISSN-L)
- 1756-8927
- OpenAlex
- W2591883888
- Cited by
- 100
- References
- 10
- FWCI
- 9.97
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.